Ultra-Early Efficacy and Hemodynamic Safety: Re-Evaluating the Magnesium Paradox
Authors:
- 22 January 2026
- journal article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 40 (4) , 1239-1240
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Association of Intravenous Magnesium Sulfate With Mortality in Patients With Myocardial Infarction: A Retrospective Cohort StudyCardiovascular Drugs and Therapy, 2025
- Effects of Angiotensin-Converting Enzyme Inhibitors/Angiotensin II Receptor Blockers on Prognosis in Acute Coronary Syndrome Patients with Preserved Ejection Fraction Undergoing Regular DialysisCardiovascular Drugs and Therapy, 2025
- Amiodarone for the Management of Acute Atrial Arrhythmias After Lung TransplantCardiovascular Drugs and Therapy, 2025
- Magnesium Sulfate in Cardiogenic Shock Patients: A Retrospective Propensity Score-Matched Cohort StudyCardiovascular Drugs and Therapy, 2025
- Geranylgeranylacetone as Prevention for Postoperative Atrial Fibrillation (GENIALITY)Cardiovascular Drugs and Therapy, 2025
- Amiodarone for the Management of Acute Atrial Arrhythmias After Lung TransplantResearch Square, 2025
- MgSO4 as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca2+ regulation of neurovascular unitsTheranostics, 2025
- Association of magnesium sulfate use with mortality in critically ill patients with sepsis: a retrospective propensity score-matched cohort studyBritish Journal of Anaesthesia, 2023
- High-Normal Serum Magnesium and Hypermagnesemia Are Associated With Increased 30-Day In-Hospital Mortality: A Retrospective Cohort StudyFrontiers in Cardiovascular Medicine, 2021
- Intravenous magnesium for acute myocardial infarction2000